• DOI:10.1081/TXR-120019021
Corpus ID: 72308933

Stonefish (Synanceia trachynis) Antivenom: In Vitro Efficacy and Clinical Use

@article{Church2003StonefishT,
  title={Stonefish (Synanceia trachynis) Antivenom: In Vitro Efficacy and Clinical Use},
  author={J. E. Church and W. Hodgson},
  journal={Journal of Toxicology: Toxin Reviews},
  year={2003},
  volume={22},
  pages={69 - 76}
}

J. E. Church, W. Hodgson

Published 2003

Medicine

Journal of Toxicology: Toxin Reviews

Certain species of fish have long been recognised as venomous. Although venomous fish do not represent a substantial source of human mortality, they are responsible for a number of envenomations each year that are serious enough to warrant clinical treatment. To the author's knowledge, the only fish antivenom still commercially available is the stonefish antivenom produced by CSL Ltd. in Australia. This antivenom consists of the purified F(ab)2 fragment of equine IgG antibodies raised against… CONTINUE READING

View on Taylor & Francis

Save to Library

Create Alert

Cite

Launch Research Feed